{"id":42271,"date":"2025-09-25T15:08:57","date_gmt":"2025-09-25T07:08:57","guid":{"rendered":"https:\/\/flcube.com\/?p=42271"},"modified":"2025-09-25T15:08:57","modified_gmt":"2025-09-25T07:08:57","slug":"microtech-medical-secures-nmpa-approval-for-equil-patch-insulin-pump-in-children-and-adolescents","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=42271","title":{"rendered":"MicroTech Medical Secures NMPA Approval for Equil Patch Insulin Pump in Children and Adolescents"},"content":{"rendered":"\n

MicroTech Medical (Hangzhou) Co., Ltd.<\/strong> (HKG: 2235<\/a>) announced that China\u2019s National Medical Products Administration (NMPA)<\/strong> has approved the Equil Patch Insulin Pump<\/strong> for use in diabetic patients aged 3\u201317 years<\/strong>. The approval expands the product\u2019s indication beyond the adult population, positioning MicroTech as a key player in pediatric diabetes care.<\/p>\n\n\n\n

Product Overview<\/h3>\n\n\n\n
    \n
  • Patch\u2011Based Delivery<\/strong> \u2013 The Equil Patch delivers insulin via a flexible, adhesive patch that continuously infuses the drug, mimicking the body\u2019s natural insulin secretion.<\/li>\n\n\n\n
  • Precision & Convenience<\/strong> \u2013 With real\u2011time glucose monitoring and adjustable basal rates, the device offers precise dosing while reducing the need for multiple injections.<\/li>\n\n\n\n
  • User\u2011Friendly Design<\/strong> \u2013 The patch\u2019s discreet, skin\u2011compatible material is suitable for children and adolescents, encouraging adherence and improving quality of life.<\/li>\n<\/ul>\n\n\n\n

    Regulatory Milestone<\/h3>\n\n\n\n
      \n
    • NMPA Approval<\/strong> \u2013 The recent clearance covers patients aged 3\u201317, a demographic for which few closed\u2011loop systems exist in China.<\/li>\n\n\n\n
    • Strategic Expansion<\/strong> \u2013 The approval follows the 2024 launch of the adult indication, marking a rapid two\u2011stage rollout within the domestic market.<\/li>\n<\/ul>\n\n\n\n

      Market Impact<\/h3>\n\n\n\n
        \n
      • Growing Pediatric Diabetes<\/strong> \u2013 China\u2019s pediatric diabetes prevalence is rising, creating a sizable unmet need for wearable insulin therapies.<\/li>\n\n\n\n
      • Competitive Edge<\/strong> \u2013 By securing pediatric approval, MicroTech positions itself ahead of competitors that still rely on traditional injections or adult\u2011only devices.<\/li>\n\n\n\n
      • Future Outlook<\/strong> \u2013 The company plans to pursue additional indications, including type\u202f1 diabetes in adolescents, and to explore international regulatory pathways in the coming year.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"

        MicroTech Medical (Hangzhou) Co., Ltd. (HKG: 2235) announced that China\u2019s National Medical Products Administration (NMPA)…<\/p>\n","protected":false},"author":1,"featured_media":42272,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,22],"tags":[39,3428,3429,15],"class_list":["post-42271","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-medical-device","tag-diabetes","tag-hkg-2235","tag-microtech-medical","tag-product-approvals"],"yoast_head":"\nMicroTech Medical Secures NMPA Approval for Equil Patch Insulin Pump in Children and Adolescents - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"MicroTech Medical (Hangzhou) Co., Ltd. (HKG: 2235) announced that China\u2019s National Medical Products Administration (NMPA) has approved the Equil Patch Insulin Pump for use in diabetic patients aged 3\u201317 years. The approval expands the product\u2019s indication beyond the adult population, positioning MicroTech as a key player in pediatric diabetes care.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=42271\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MicroTech Medical Secures NMPA Approval for Equil Patch Insulin Pump in Children and Adolescents\" \/>\n<meta property=\"og:description\" content=\"MicroTech Medical (Hangzhou) Co., Ltd. (HKG: 2235) announced that China\u2019s National Medical Products Administration (NMPA) has approved the Equil Patch Insulin Pump for use in diabetic patients aged 3\u201317 years. The approval expands the product\u2019s indication beyond the adult population, positioning MicroTech as a key player in pediatric diabetes care.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=42271\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-25T07:08:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2512.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42271#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42271\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"MicroTech Medical Secures NMPA Approval for Equil Patch Insulin Pump in Children and Adolescents\",\"datePublished\":\"2025-09-25T07:08:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42271\"},\"wordCount\":247,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42271#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/2512.webp\",\"keywords\":[\"Diabetes\",\"HKG: 2235\",\"MicroTech Medical\",\"Product approvals\"],\"articleSection\":[\"Company\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=42271#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42271\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=42271\",\"name\":\"MicroTech Medical Secures NMPA Approval for Equil Patch Insulin Pump in Children and Adolescents - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42271#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42271#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/2512.webp\",\"datePublished\":\"2025-09-25T07:08:57+00:00\",\"description\":\"MicroTech Medical (Hangzhou) Co., Ltd. (HKG: 2235) announced that China\u2019s National Medical Products Administration (NMPA) has approved the Equil Patch Insulin Pump for use in diabetic patients aged 3\u201317 years. The approval expands the product\u2019s indication beyond the adult population, positioning MicroTech as a key player in pediatric diabetes care.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42271#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=42271\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42271#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/2512.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/2512.webp\",\"width\":1080,\"height\":608,\"caption\":\"MicroTech Medical Secures NMPA Approval for Equil Patch Insulin Pump in Children and Adolescents\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42271#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MicroTech Medical Secures NMPA Approval for Equil Patch Insulin Pump in Children and Adolescents\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MicroTech Medical Secures NMPA Approval for Equil Patch Insulin Pump in Children and Adolescents - Insight, China's Pharmaceutical Industry","description":"MicroTech Medical (Hangzhou) Co., Ltd. (HKG: 2235) announced that China\u2019s National Medical Products Administration (NMPA) has approved the Equil Patch Insulin Pump for use in diabetic patients aged 3\u201317 years. The approval expands the product\u2019s indication beyond the adult population, positioning MicroTech as a key player in pediatric diabetes care.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=42271","og_locale":"en_US","og_type":"article","og_title":"MicroTech Medical Secures NMPA Approval for Equil Patch Insulin Pump in Children and Adolescents","og_description":"MicroTech Medical (Hangzhou) Co., Ltd. (HKG: 2235) announced that China\u2019s National Medical Products Administration (NMPA) has approved the Equil Patch Insulin Pump for use in diabetic patients aged 3\u201317 years. The approval expands the product\u2019s indication beyond the adult population, positioning MicroTech as a key player in pediatric diabetes care.","og_url":"https:\/\/flcube.com\/?p=42271","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-09-25T07:08:57+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2512.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=42271#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=42271"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"MicroTech Medical Secures NMPA Approval for Equil Patch Insulin Pump in Children and Adolescents","datePublished":"2025-09-25T07:08:57+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=42271"},"wordCount":247,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=42271#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2512.webp","keywords":["Diabetes","HKG: 2235","MicroTech Medical","Product approvals"],"articleSection":["Company","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=42271#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=42271","url":"https:\/\/flcube.com\/?p=42271","name":"MicroTech Medical Secures NMPA Approval for Equil Patch Insulin Pump in Children and Adolescents - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=42271#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=42271#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2512.webp","datePublished":"2025-09-25T07:08:57+00:00","description":"MicroTech Medical (Hangzhou) Co., Ltd. (HKG: 2235) announced that China\u2019s National Medical Products Administration (NMPA) has approved the Equil Patch Insulin Pump for use in diabetic patients aged 3\u201317 years. The approval expands the product\u2019s indication beyond the adult population, positioning MicroTech as a key player in pediatric diabetes care.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=42271#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=42271"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=42271#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2512.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2512.webp","width":1080,"height":608,"caption":"MicroTech Medical Secures NMPA Approval for Equil Patch Insulin Pump in Children and Adolescents"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=42271#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"MicroTech Medical Secures NMPA Approval for Equil Patch Insulin Pump in Children and Adolescents"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2512.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=42271"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42271\/revisions"}],"predecessor-version":[{"id":42273,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42271\/revisions\/42273"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/42272"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=42271"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=42271"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=42271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}